Acer Therapeutics Inc(NASDAQ:ACER) 
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-05-24
P
O 0.85
H 1.03
L 0.85
C 0.90
V 746,022
10EMA 0.90
20EMA 0.90
60EMA 0.90
120EMA 0.90
250EMA 0.90